Royal Bank of Canada’s Ardent Health ARDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1K Sell
150
-660
-81% -$5.92K ﹤0.01% 6989
2025
Q4
$7K Sell
810
-33,970
-98% -$393K ﹤0.01% 6611
2025
Q3
$461K Buy
34,780
+32,673
+1,551% +$409K ﹤0.01% 4551
2025
Q2
$29K Buy
2,107
+717
+52% +$9.65K ﹤0.01% 6143
2025
Q1
$19K Buy
1,390
+39
+3% +$569 ﹤0.01% 5944
2024
Q4
$23K Sell
1,351
-212
-14% -$3.67K ﹤0.01% 6065
2024
Q3
$29K Buy
+1,563
New +$27.6K ﹤0.01% 5963

Other funds holding ARDT

Royal Bank of Canada's ARDT Position: Q1 2026 in Review

Royal Bank of Canada reduced its Ardent Health (ARDT) stake by 81% in Q1 2026, selling an estimated $5.92K and leaving 150 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #6989.

Royal Bank of Canada first reported a position in ARDT in Q3 2024 and has held it in 7 quarters since. The position peaked at $461K in Q3 2025. 136 funds tracked by Wall St. Rank hold ARDT as of Q1 2026.

  • Royal Bank of Canada held 150 shares of Ardent Health worth $1K as of Q1 2026.
  • Royal Bank of Canada sold 660 Ardent Health shares in Q1 2026, an estimated $5.92K.
  • Ardent Health made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #6989 holding.
  • Royal Bank of Canada first reported a position in Ardent Health in Q3 2024 and has held it in 7 quarters since.
  • Royal Bank of Canada's Ardent Health position peaked at $461K in Q3 2025.
  • 136 funds tracked by Wall St. Rank held Ardent Health as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.